RHJA
CLVS
Rice Hall James & Associates’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-208,053
| Closed | -$3.09M | – | 293 |
|
|
2019
Q2 | $3.09M | Sell |
208,053
-14,112
| -6% | -$210K | 0.1% | 137 |
|
|
2019
Q1 | $5.51M | Buy |
222,165
+11,743
| +6% | +$291K | 0.18% | 127 |
|
|
2018
Q4 | $3.78M | Buy |
210,422
+61,210
| +41% | +$1.1M | 0.14% | 129 |
|
|
2018
Q3 | $4.38M | Sell |
149,212
-4,903
| -3% | -$144K | 0.16% | 121 |
|
|
2018
Q2 | $7.01M | Buy |
154,115
+6,036
| +4% | +$274K | 0.25% | 111 |
|
|
2018
Q1 | $7.82M | Buy |
148,079
+429
| +0.3% | +$22.7K | 0.31% | 99 |
|
|
2017
Q4 | $10M | Buy |
147,650
+25,985
| +21% | +$1.77M | 0.39% | 92 |
|
|
2017
Q3 | $10M | Sell |
121,665
-4,748
| -4% | -$391K | 0.44% | 88 |
|
|
2017
Q2 | $11.8M | Buy |
126,413
+25,487
| +25% | +$2.39M | 0.51% | 83 |
|
|
2017
Q1 | $6.43M | Sell |
100,926
-3,382
| -3% | -$215K | 0.31% | 96 |
|
|
2016
Q4 | $4.63M | Sell |
104,308
-1,899
| -2% | -$84.3K | 0.23% | 97 |
|
|
2016
Q3 | $3.83M | Buy |
106,207
+11,613
| +12% | +$419K | 0.2% | 102 |
|
|
2016
Q2 | $1.3M | Buy |
94,594
+1,716
| +2% | +$23.5K | 0.07% | 231 |
|
|
2016
Q1 | $1.78M | Buy |
92,878
+3,855
| +4% | +$74K | 0.1% | 189 |
|
|
2015
Q4 | $3.12M | Buy |
89,023
+39,015
| +78% | +$1.37M | 0.18% | 117 |
|
|
2015
Q3 | $4.6M | Buy |
50,008
+20,516
| +70% | +$1.89M | 0.3% | 81 |
|
|
2015
Q2 | $2.59M | Sell |
29,492
-2,863
| -9% | -$252K | 0.15% | 150 |
|
|
2015
Q1 | $2.4M | Buy |
+32,355
| New | +$2.4M | 0.14% | 165 |
|